Efficacy and safety under field conditions of the new vaccine UBAC® against Streptococcus uberis intramammary infections in dairy cows

Inicio Conocimiento Efficacy and safety under field conditions of the new vaccine UBAC® against Streptococcus uberis intramammary infections in dairy cows

Efficacy and safety under field conditions of the new vaccine UBAC® against Streptococcus uberis intramammary infections in dairy cows

To evaluate the ef­ficacy and safety under ­field conditions of the new vaccine UBAC® (HIPRA) through a multicenter, randomized, double blinded and placebo-controlled clinical trial.

Sobre este artículo

Apareció en

National Mastitis Council, 2018

Fecha

11 jun. 2018

Autores

Puig, A.; Perozo, E.; Roura, F.; Armengol, R.; Ponté, D.; Mallo, J.; Echevarria, J.M.; Arrieta, C.; Herrera, D.; Franquesa, O.; Urtado, L.; Calm, I.; Collado, R.; Prenafeta, T.; March, R.; Sabaté, D.

Resumen

Incidence of animals with S. uberis CM was significantly lower in UBAC® group than in the Placebo group (Figure 2). Also, differences between groups in terms of incidence of animals with S. uberis ScM were not statistically significant.

Compartir en